Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab

被引：4
|
作者：
Hertler, Caroline [1 ,2 ,3 ]
Seystahl, Katharina [1 ,2 ]
Le Rhun, Emilie [1 ,2 ,4 ]
Wirsching, Hans-Georg [1 ,2 ]
Roth, Patrick [1 ,2 ]
Weller, Michael [1 ,2 ]
Gramatzki, Dorothee [1 ,2 ]
机构：
[1] Univ Hosp, Clin Neurosci Ctr, Dept Neurol, Frauenklin str 26, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Frauenklin str 26, CH-8091 Zurich, Switzerland
[3] Univ Hosp Zurich, Competence Ctr Palliat Care, Zurich, Switzerland
[4] Univ Hosp, Clin Neurosci Ctr, Dept Neurosurg, Zurich, Switzerland
来源：
NEURO-ONCOLOGY | 2022年 / 24卷 / 11期
关键词：
D O I：
10.1093/neuonc/noac172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2001 / 2004
页数：4
相关论文
共 50 条
  • [31] The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab
    Gahrmann, Renske
    Smits, Marion
    Vernhout, Rene Michel
    Taal, Walter
    Kapsas, Giorgios
    de Groot, Jan Cees
    Hanse, Monique
    Vos, Maaike
    Beerepoot, Laurens Victor
    Buter, Jan
    Flach, Zwenneke Hendrieke
    van der Holt, Bronno
    van den Bent, Martin
    [J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [32] Prognostic value of relative cerebral blood volume in patients with recurrent glioblastoma multiforme treated with bevacizumab
    Stecco, Alessandro
    Amatuzzo, Paola
    Sponghini, Andrea P.
    Platini, Francesca
    Quagliozzi, Martina
    Buemi, Francesco
    Guenzi, Elena
    Carriero, Alessandro
    [J]. JOURNAL OF NEUROSURGICAL SCIENCES, 2019, 63 (04) : 394 - 401
  • [33] Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin
    Iwan E. Bennett
    Kathryn M. Field
    Christopher M. Hovens
    Bradford A. Moffat
    Mark A. Rosenthal
    Katharine Drummond
    Andrew H. Kaye
    Andrew P. Morokoff
    [J]. Journal of Neuro-Oncology, 2017, 131 : 321 - 329
  • [34] Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study
    M. C. Morisse
    N. Etienne-Selloum
    D. Bello-Roufai
    M. Blonski
    L. Taillandier
    V. Lorgis
    G. Noël
    G. Ahle
    A. Durán-Peña
    M. Boone
    B. Chauffert
    [J]. Journal of Neuro-Oncology, 2019, 144 : 419 - 426
  • [35] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    David Schiff
    Benjamin Purow
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 186 - 187
  • [36] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    Jakobsen, J. N.
    Urup, T.
    Grunnet, K.
    Toft, A.
    Johansen, M. D.
    Poulsen, S. H.
    Christensen, I. J.
    Muhic, A.
    Poulsen, H. S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 439 - 446
  • [37] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    J. N. Jakobsen
    T. Urup
    K. Grunnet
    A. Toft
    M. D. Johansen
    S. H. Poulsen
    I. J. Christensen
    A. Muhic
    H. S. Poulsen
    [J]. Journal of Neuro-Oncology, 2018, 137 : 439 - 446
  • [38] Outcomes in Patients with Recurrent/Progressive Glioblastoma Treated with Bevacizumab Funded by a Regional Cancer Drug Fund
    Dixit, S.
    Hatfield, P.
    Clenton, S.
    Loughrey, C.
    Hingorani, M.
    [J]. CLINICAL ONCOLOGY, 2014, 26 (04) : 238 - 239
  • [39] CIRCULATING BLOOD CELL COUNTS AS POTENTIAL BIOMARKERS OF OUTCOMES IN RECURRENT GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB
    Vaios, Eugene
    Winter, Sebastian
    Muzikansky, Alona
    Nahed, Brian
    Dietrich, Jorg
    [J]. NEURO-ONCOLOGY, 2018, 20 : 116 - 116
  • [40] Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice
    Desjardins, Annick
    Herndon, James E., II
    McSherry, Frances
    Ravelo, Arliene
    Lipp, Eric S.
    Healy, Patrick
    Peters, Katherine B.
    Sampson, John H.
    Randazzo, Dina
    Sommer, Nicolas
    Friedman, Allan H.
    Friedman, Henry S.
    [J]. HEALTH SCIENCE REPORTS, 2019, 2 (04)
12345